122 related articles for article (PubMed ID: 29259008)
1. CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.
Klein S; Abraham M; Bulvik B; Dery E; Weiss ID; Barashi N; Abramovitch R; Wald H; Harel Y; Olam D; Weiss L; Beider K; Eizenberg O; Wald O; Galun E; Pereg Y; Peled A
Cancer Res; 2018 Mar; 78(6):1471-1483. PubMed ID: 29259008
[TBL] [Abstract][Full Text] [Related]
2. The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.
Abraham M; Klein S; Bulvik B; Wald H; Weiss ID; Olam D; Weiss L; Beider K; Eizenberg O; Wald O; Galun E; Avigdor A; Benjamini O; Nagler A; Pereg Y; Tavor S; Peled A
Leukemia; 2017 Nov; 31(11):2336-2346. PubMed ID: 28280274
[TBL] [Abstract][Full Text] [Related]
3. CXCL12/CXCR4 axis induced miR-125b promotes invasion and confers 5-fluorouracil resistance through enhancing autophagy in colorectal cancer.
Yu X; Shi W; Zhang Y; Wang X; Sun S; Song Z; Liu M; Zeng Q; Cui S; Qu X
Sci Rep; 2017 Feb; 7():42226. PubMed ID: 28176874
[TBL] [Abstract][Full Text] [Related]
4. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
[TBL] [Abstract][Full Text] [Related]
5. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
[TBL] [Abstract][Full Text] [Related]
7. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
8. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities.
Bonci D; Coppola V; Musumeci M; Addario A; Giuffrida R; Memeo L; D'Urso L; Pagliuca A; Biffoni M; Labbaye C; Bartucci M; Muto G; Peschle C; De Maria R
Nat Med; 2008 Nov; 14(11):1271-7. PubMed ID: 18931683
[TBL] [Abstract][Full Text] [Related]
9. Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.
Soriano A; Masanas M; Boloix A; Masiá N; París-Coderch L; Piskareva O; Jiménez C; Henrich KO; Roma J; Westermann F; Stallings RL; Sábado C; de Toledo JS; Santamaria A; Gallego S; Segura MF
Cell Mol Life Sci; 2019 Jun; 76(11):2231-2243. PubMed ID: 30770954
[TBL] [Abstract][Full Text] [Related]
10. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
Opel D; Naumann I; Schneider M; Bertele D; Debatin KM; Fulda S
Clin Cancer Res; 2011 May; 17(10):3233-47. PubMed ID: 21355080
[TBL] [Abstract][Full Text] [Related]
11. Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma.
Zagozdzon R; Fu Y; Avraham HK
Int J Oncol; 2008 Mar; 32(3):619-23. PubMed ID: 18292939
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of the oncogene lncRNA NEAT1 restores the availability of
Hu Y; Yang Q; Wang L; Wang S; Sun F; Xu D; Jiang J
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654165
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
Zhu Y; Wen X; Zhao P
Med Sci Monit; 2018 Jun; 24():3679-3692. PubMed ID: 29858490
[TBL] [Abstract][Full Text] [Related]
14. LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer.
Wang L; Zhang X; Sheng L; Qiu C; Luo R
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126852
[TBL] [Abstract][Full Text] [Related]
15. Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth.
Lamers F; Schild L; den Hartog IJ; Ebus ME; Westerhout EM; Ora I; Koster J; Versteeg R; Caron HN; Molenaar JJ
Eur J Cancer; 2012 Nov; 48(16):3093-103. PubMed ID: 22366560
[TBL] [Abstract][Full Text] [Related]
16. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.
Cai CK; Zhao GY; Tian LY; Liu L; Yan K; Ma YL; Ji ZW; Li XX; Han K; Gao J; Qiu XC; Fan QY; Yang TT; Ma BA
Oncol Rep; 2012 Nov; 28(5):1764-70. PubMed ID: 22922827
[TBL] [Abstract][Full Text] [Related]
17. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.
Hart LS; Rader J; Raman P; Batra V; Russell MR; Tsang M; Gagliardi M; Chen L; Martinez D; Li Y; Wood A; Kim S; Parasuraman S; Delach S; Cole KA; Krupa S; Boehm M; Peters M; Caponigro G; Maris JM
Clin Cancer Res; 2017 Apr; 23(7):1785-1796. PubMed ID: 27729458
[No Abstract] [Full Text] [Related]
19. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
20. microRNA-221 Enhances MYCN via Targeting Nemo-like Kinase and Functions as an Oncogene Related to Poor Prognosis in Neuroblastoma.
He XY; Tan ZL; Mou Q; Liu FJ; Liu S; Yu CW; Zhu J; Lv LY; Zhang J; Wang S; Bao LM; Peng B; Zhao H; Zou L
Clin Cancer Res; 2017 Jun; 23(11):2905-2918. PubMed ID: 28003306
[No Abstract] [Full Text] [Related]
[Next] [New Search]
